Compare Agilent Technologies Inc (A) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Agilent Technologies Inc trades at $128.67 (market cap $37.04B), while iShares 20 Plus Year Treasury Bond ETF trades at $84.43. The key difference: Agilent Technologies Inc pays a 0.78% dividend while iShares 20 Plus Year Treasury Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares 20 Plus Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | TLT | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | — |
52-Week High | $157.20 | $92.06 |
52-Week Low | $110.24 | $83.02 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
TLT, the iShares 20+ Year Treasury Bond ETF, trades at $84.55, down 1.12% on the day, reflecting ongoing bearish pressure in the long-duration Treasury market. Technical indicators are predominantly bearish, with moving averages signaling a strong sell, while oscillators remain neutral. The fund has faced significant drawdowns recently, losing nearly 48% since 2020, but now offers higher starting yields, attracting investor attention amid shifting Fed policy expectations and inflation concerns.
The outlook for TLT hinges on Federal Reserve interest rate decisions and inflation trends. Opportunities exist for yield-seeking investors due to elevated distributions, but risks include potential further rate hikes, prolonged high inflation, and interest rate sensitivity. Market sentiment is mixed, with some analysts seeing value after the steep decline, while others caution about duration risk in a volatile macroeconomic environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →
